Abstract
Anterior cruciate ligament (ACL) injury initiates a biochemical cascade thought to contribute to the onset and progression of posttraumatic osteoarthritis (PTOA). Interleukin-1ß (IL-1ß), IL-6, and C-telopeptide fragments of type II collagen (CTX-II) are implicated in joint inflammation and cartilage degradation following ACL injury; however, their association with pain is still being explored. The purpose of this study was to evaluate the associations between synovial fluid concentrations of IL-1ß, IL-6, and CTX-II with pain following ACL injury and reconstruction. We hypothesized that greater IL-1ß, IL-6, and CTX-II would correlate with greater Pain Visual Analogue Scale (VAS) scores. This was a secondary analysis of 23 patients (mean age = 18.4 years, BMI = 27.4, 13 females/10 males) with acute ACL tears who participated in a pilot randomized trial. Synovial fluid and VAS scores were collected on the day of initial presentation, at ACL reconstruction, and 1 and 4 weeks after surgery. Synovial fluid concentrations of IL-1ß, IL-6, and CTX-II were assessed using enzyme-linked immunoabsorbent assays, and repeated measures correlations were used to assess the relationships between pain and synovial IL-1ß, IL-6, or CTX-II after ACL injury and reconstruction. Pain was positively correlated with synovial fluid IL-6 concentrations (r = 0.52, p < 0.001); however, pain was inversely correlated with CTX-II (r = −0.39, p = 0.002). IL-1ß had no significant correlation with pain. Statement of clinical relevance: PTOA has been described as a “silent killer” and these results suggest that early PTOA may have pro-inflammatory pathways that are not primarily associated with pain but still lead to progressive cartilage loss.
| Original language | English |
|---|---|
| Pages (from-to) | 300-306 |
| Number of pages | 7 |
| Journal | Journal of Orthopaedic Research |
| Volume | 41 |
| Issue number | 2 |
| DOIs | |
| State | Published - Feb 2023 |
Bibliographical note
Publisher Copyright:© 2022 Orthopaedic Research Society. Published by Wiley Periodicals LLC.
Funding
Funding was provided in part by the University of Kentucky College of Medicine MVP Grant; NIH National Center for Advancing Translational Sciences, Grant/Award Number: UL1TR001998. Disclosures: Austin Stone (3C‐Allosource, 3C‐Smith & Nephew, 5‐Allosource, 5‐Flexion Therapeutics, 9‐AOSSM, 9‐AANA), Christian Lattermann (3B‐Samumed, Vericel, Joint Restoration Foundation; 8‐Cartilage, J Sports Physiology, The Knee, OJSM; 9‐Biologic Association, International Cartilage Repair Society), Cale Jacobs (5‐Flexion Therapeutics, 5‐Smith & Nephew, 8‐VJSM). Funding was provided in part by the University of Kentucky College of Medicine MVP Grant; NIH National Center for Advancing Translational Sciences, Grant/Award Number: UL1TR001998. Disclosures: Austin Stone (3C-Allosource, 3C-Smith & Nephew, 5-Allosource, 5-Flexion Therapeutics, 9-AOSSM, 9-AANA), Christian Lattermann (3B-Samumed, Vericel, Joint Restoration Foundation; 8-Cartilage, J Sports Physiology, The Knee, OJSM; 9-Biologic Association, International Cartilage Repair Society), Cale Jacobs (5-Flexion Therapeutics, 5-Smith & Nephew, 8-VJSM).
| Funders | Funder number |
|---|---|
| 9-Biologic Association | |
| International Cartilage Repair Society | 8-VJSM |
| University of Kentucky College of Medicine | |
| National Center for Advancing Translational Sciences (NCATS) | UL1TR001998, 9-AANA, 9-AOSSM |
Keywords
- anterior cruciate ligament
- biomarker
- cartilage
- knee
- pain
ASJC Scopus subject areas
- Orthopedics and Sports Medicine